Literature DB >> 17290743

[Study on association of interleukin-1 receptor antagonist(RA) gene + 2018 locus mutation with silicosis].

De-jun Wang1, Yue-lin Yang, Qing-jie Xia, Ya-jia Lan, Mian-zhen Wang, Ji-ping Han, Yu-lin Yang, Fan-ling Kong.   

Abstract

OBJECTIVE: To approach whether + 2018 locus (T-- C) mutation within the interleukin- receptor antagonist (IL-1RA) gene promoter region are associated with susceptibility to silicosis in Southwest Chinese Han population.
METHODS: 75 cases of silicosis and 137 silica-exposed workers(being employed) were selected as subjects.5ml peripheral vein blood was drawn from each subject. By real-time quantitative polymerase chain reaction and sequencing techniques, IL-1RA gene mutation of all subjects were analyzed.
RESULTS: The frequency of IL-1RA + 2018C among the cases with silicosis was higher than that among the silica-exposed workers (controls) (28.0% versus 15.0% , Fisher' s exact P < 0.01 ). The frequency of allelic C was higher in cases with phase I silicosis than in controls(31.8% versus 15.0%, Fisher's exact P < 0.01 ). The frequency of allelic C was higher in cases with phase I and Ill silicosis than in controls, but which statistic difference being not significant(22.6% versus 15.0%, Fisher's exact P < 0.01). After adjusted for confounding factors, the frequency of IL-1RA + 2018C among silicoses and its subgroups was still higher than among controls, which statistic difference being significant (Fisher' s exact P < 0.01).
CONCLUSION: IL-1RA gene polymorphisms played an important role in making the Han population of Southwest China susceptible to silicosis. IL-1RA might be took as a gene to be selected for studying the susceptibility of silicosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17290743

Source DB:  PubMed          Journal:  Wei Sheng Yan Jiu        ISSN: 1000-8020


  1 in total

1.  IL-1RA +2018 polymorphism and the susceptivity to pneumoconiosis: a Meta-analysis.

Authors:  Yan Zhou; Yan Kang; Zhongwei Zhang; Jin Liu
Journal:  Int J Clin Exp Med       Date:  2014-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.